Tu1007 - Elderly Patients may not Receive Benefit of Vonoprazan in Triple Therapy in a Separate Tablet for First-Line Eradication Against Helicobater Pylori

Tsutomu Nishida; Yu Higaki; Ryo Tomita; Hiromi Shimakoshi; Akiyoshi Shimoda; Naoto Osugi; Aya Sugimoto; Kei Takahashi; Kaori Mukai; Dai Nakamatsu; Tokuhiro Matsubara; Masashi Yamamoto; Shiro Hayashi; Sachiko Nakajima; Koji Fukui; Masami Inada

doi:10.1016/s0016-5085(18)32999-8

Tu1007 - Elderly Patients may not Receive Benefit of Vonoprazan in Triple Therapy in a Separate Tablet for First-Line Eradication Against Helicobater Pylori

Gastroenterology ◽

10.1016/s0016-5085(18)32999-8 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-888

Author(s):

Tsutomu Nishida ◽

Yu Higaki ◽

Ryo Tomita ◽

Hiromi Shimakoshi ◽

Akiyoshi Shimoda ◽

...

Keyword(s):

Elderly Patients ◽

Triple Therapy ◽

First Line ◽

Separate Tablet

Download Full-text

Effectiveness of 14-days course of clarithromycin-based triple therapy as first line therapy for h.pylori infection in egyptian elderly patients

The Egyptian Journal of Geriatrics and Gerontology ◽

10.21608/ejgg.2015.5342 ◽

2015 ◽

Vol 2 (1) ◽

pp. 19-26

Author(s):

Salamah M ◽

Gad M. ◽

Deghady A. ◽

Elgayar H

Keyword(s):

Elderly Patients ◽

Triple Therapy ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text

First-line temozolomide therapy and MGMT status in elderly patients with primary CNS lymphoma

Aktuelle Neurologie ◽

10.1055/s-0029-1238745 ◽

2009 ◽

Vol 36 (S 02) ◽

Author(s):

M Glas ◽

D Kurzwelly ◽

P Roth ◽

K Rasch ◽

E Weimann ◽

...

Keyword(s):

Elderly Patients ◽

Primary Cns Lymphoma ◽

Cns Lymphoma ◽

First Line

Download Full-text

Efficacy and tolerability of a triple therapy containing a potassium-competitive acid blocker as first-line treatment for Helicobacter pylori infection

10.26226/morressier.57c53841d462b80296c9c9d4 ◽

2016 ◽

Author(s):

Sho Suzuki

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Helicobacter Pylori Infection ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1094856.549783 ◽

2007 ◽

Author(s):

Ian Beales

Keyword(s):

Helicobacter Pylori ◽

Proton Pump Inhibitor ◽

Triple Therapy ◽

Proton Pump ◽

Meta Analysis ◽

First Line ◽

Helicobacter Pylori Eradication

Download Full-text

Faculty Opinions recommendation of First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162774.624372 ◽

2009 ◽

Author(s):

Ulrich Wedding

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Elderly Patients ◽

Lymphocytic Leukemia ◽

First Line ◽

First Line Therapy ◽

Major Benefit ◽

Line Therapy

Download Full-text

Faculty Opinions recommendation of Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717950069.793455913 ◽

2012 ◽

Author(s):

David Murdoch

Keyword(s):

Clinical Trial ◽

Helicobacter Pylori ◽

Randomized Clinical Trial ◽

Triple Therapy ◽

First Line ◽

Helicobacter Pylori Eradication ◽

Therapy Regimen ◽

Triple Therapy Regimen ◽

Single Blind

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964584.793468557 ◽

2013 ◽

Author(s):

Bruno Andreoni ◽

Gianmarco Contino

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Safety And Efficacy ◽

First Line Therapy ◽

Line Therapy

Download Full-text

Faculty Opinions recommendation of Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964930.793468200 ◽

2012 ◽

Author(s):

Yoshio Yamaoka ◽

Seiji Shiota

Keyword(s):

Helicobacter Pylori ◽

Triple Therapy ◽

Randomised Trial ◽

Line Treatment ◽

First Line ◽

Open Label ◽

First Line Treatment

Download Full-text

Faculty Opinions recommendation of Development of a geriatric vulnerability score in elderly patients with advanced ovarian cancer treated with first-line carboplatin: a GINECO prospective trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718118520.793489565 ◽

2014 ◽

Author(s):

Roberto Sorio

Keyword(s):

Ovarian Cancer ◽

Elderly Patients ◽

Prospective Trial ◽

Advanced Ovarian Cancer ◽

First Line ◽

Vulnerability Score

Download Full-text

Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases

Scandinavian Journal of Gastroenterology ◽

10.1080/00365521.2021.1946588 ◽

2021 ◽

pp. 1-9

Author(s):

Mohamed Attauabi ◽

Camilla Höglund ◽

Janne Fassov ◽

Kenneth Bo Pedersen ◽

Heidi Bansholm Hansen ◽

...

Keyword(s):

Elderly Patients ◽

Real World ◽

Inflammatory Bowel Diseases ◽

Biological Therapy ◽

First Line ◽

Bowel Diseases ◽

Inflammatory Bowel

Download Full-text